Deciduous Therapeutics Investor
Developer of novel therapeutics designed for the treatment of age-related diseases. The company's novel molecules can activate a critical endogenous immune surveillance mechanism to selectively remove senescent cells, enabling healthcare providers to treat several classes of age-related Therapeutics 2025 : Valuation, ?
Investors
Technology:
Biotechnology
Founded Date:
2019.0
Employee Number:
14
Headquarters:
953 Indiana St, San Francisco, CA 94107
Estimated Revenue:
26.5M.